Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness

C. Timmermann, JW. Sanders, D. Reydellet, T. Barba, LX. Luan, ÓS. Angona, G. Ona, G. Allocca, CH. Smith, ZG. Daily, NL. Mason, L. Kloft-Heller, M. Kuchar, L. Janeckova, T. Palenicek, D. Erritzoe, JG. Ramaekers, RL. Carhart-Harris, MV. Uthaug

. 2025 ; 2025 (1) : niaf007. [pub] 20250419

Status neindexováno Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25014513

5-MeO-DMT is a short-acting psychedelic that is anecdotally reported to induce a radical disruption of the self and a paradoxical quality of aroused, waking awareness that is nevertheless devoid of any specific perceptual contents. Here, we conducted an exploratory observational study of the phenomenological and neuronal effects of this compound. We collected micro-phenomenological interviews, psychometric questionnaires, and electroencephalography (EEG) in naturalistic ceremonial settings where 5-MeO-DMT was ingested. Results revealed that the 5-MeO-DMT experience followed a dynamic progression that-only in the most extreme cases-manifested as a complete absence of self-experience and other phenomenal content with preserved awareness. Furthermore, visual imagery, bodily self-disruption, narrative self-disruption, and reduced phenomenal distinctions occurred in a variable fashion. EEG analyses revealed the 5-MeO-DMT experience was characterised by (global) alpha and (posterior) beta power reductions, implying a mode of brain functioning where top-down models are inhibited. Our preliminary phenomenological findings confirm the potential utility of 5-MeO-DMT as a pharmacological model for deconstructed consciousness while noting the limitations of employing retrospective questionnaires for this purpose. Considering the exploratory nature of this study and its limitations inherent to its naturalistic nature, further research employing real-time experience sampling and phenomenologically trained participants in controlled environments could expand our findings to meaningfully inform the potential of this tool for the scientific study of consciousness.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25014513
003      
CZ-PrNML
005      
20250905141442.0
007      
ta
008      
250701s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/nc/niaf007 $2 doi
035    __
$a (PubMed)40260121
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Timmermann, Christopher $u DMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK $u Department of Experimental Psychology, University College London, London WC1H 0AP, UK $1 https://orcid.org/000000022281377X
245    10
$a Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness / $c C. Timmermann, JW. Sanders, D. Reydellet, T. Barba, LX. Luan, ÓS. Angona, G. Ona, G. Allocca, CH. Smith, ZG. Daily, NL. Mason, L. Kloft-Heller, M. Kuchar, L. Janeckova, T. Palenicek, D. Erritzoe, JG. Ramaekers, RL. Carhart-Harris, MV. Uthaug
520    9_
$a 5-MeO-DMT is a short-acting psychedelic that is anecdotally reported to induce a radical disruption of the self and a paradoxical quality of aroused, waking awareness that is nevertheless devoid of any specific perceptual contents. Here, we conducted an exploratory observational study of the phenomenological and neuronal effects of this compound. We collected micro-phenomenological interviews, psychometric questionnaires, and electroencephalography (EEG) in naturalistic ceremonial settings where 5-MeO-DMT was ingested. Results revealed that the 5-MeO-DMT experience followed a dynamic progression that-only in the most extreme cases-manifested as a complete absence of self-experience and other phenomenal content with preserved awareness. Furthermore, visual imagery, bodily self-disruption, narrative self-disruption, and reduced phenomenal distinctions occurred in a variable fashion. EEG analyses revealed the 5-MeO-DMT experience was characterised by (global) alpha and (posterior) beta power reductions, implying a mode of brain functioning where top-down models are inhibited. Our preliminary phenomenological findings confirm the potential utility of 5-MeO-DMT as a pharmacological model for deconstructed consciousness while noting the limitations of employing retrospective questionnaires for this purpose. Considering the exploratory nature of this study and its limitations inherent to its naturalistic nature, further research employing real-time experience sampling and phenomenologically trained participants in controlled environments could expand our findings to meaningfully inform the potential of this tool for the scientific study of consciousness.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sanders, James W $u DMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK
700    1_
$a Reydellet, David $u DMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK
700    1_
$a Barba, Tommaso $u DMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK
700    1_
$a Luan, Lisa X $u DMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK
700    1_
$a Angona, Óscar Soto $u Parc Sanitari Sant Joan de Dèu, Barcelona 08830, Spain $u Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona 08193, Spain
700    1_
$a Ona, Genís $u Parc Sanitari Sant Joan de Dèu, Barcelona 08830, Spain $u Fundació Sant Joan de Déu, Barcelona 08014, Spain $u Medical Anthropology Research Center (MARC), Universitat Rovira i Virgili, Tarragona 43005, Spain
700    1_
$a Allocca, Giancarlo $u Florey Department of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria 3052, Australia $u Somnivore Pty Ltd, Melbourne, Victoria 3340, Australia
700    1_
$a Smith, Carl H $u Department of Media, School of the Arts and Creative Industries, University of East London, London, E16 2RD, UK
700    1_
$a Daily, Zachary G $u DMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK
700    1_
$a Mason, Natasha L $u Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, 6229, the Netherlands
700    1_
$a Kloft-Heller, Lilian $u Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, 6229, the Netherlands
700    1_
$a Kuchar, Martin $u Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague 166 28, Czech Republic
700    1_
$a Janeckova, Lucie $u Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague 166 28, Czech Republic
700    1_
$a Palenicek, Tomas $u Psychedelic Research Center, National Institute of Mental Health, Klecany 250 67, Czech Republic $u 3rd Faculty of Medicine, Charles University in Prague, Prague 100 00, Czech Republic
700    1_
$a Erritzoe, David $u DMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK
700    1_
$a Ramaekers, Johannes G $u Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, 6229, the Netherlands
700    1_
$a Carhart-Harris, Robin L $u DMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK $u Department of Neurology, University of California San Francisco, San Francisco 94143, USA
700    1_
$a Uthaug, Malin Vedøy $u DMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK $u Somnivore Pty Ltd, Melbourne, Victoria 3340, Australia $u Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, 6229, the Netherlands
773    0_
$w MED00208621 $t Neuroscience of consciousness $x 2057-2107 $g Roč. 2025, č. 1 (2025), s. niaf007
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40260121 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250701 $b ABA008
991    __
$a 20250905141430 $b ABA008
999    __
$a ok $b bmc $g 2388105 $s 1251633
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2025 $b 2025 $c 1 $d niaf007 $e 20250419 $i 2057-2107 $m Neuroscience of consciousness $n Neurosci Conscious $x MED00208621
LZP    __
$a Pubmed-20250701

Najít záznam

Citační ukazatele

Možnosti archivace